Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study

Main Article Content

Loretta Fiorillo
Emily Becker
Raul de Lucas
Anna Belloni-Fortina
Susana Armesto
Peter Maes
Rajneet Oberoi
Maria Paris
Wendy Zhang
Zuoshun Zhang
Lisa Arkin


Apremilast, Plaque Psoriasis, Pediatrics


1. Papp K, et al. J Am Adad Dermatol. 2015;73:37–49.

2. Paul C, et al. Br J Dermatol. 2015;173:1387-1399.

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.